Differential expression of glucocorticoid receptor transcripts in major depressive disorder is not epigenetically programmed
- PMID: 19782477
- DOI: 10.1016/j.psyneuen.2009.09.001
Differential expression of glucocorticoid receptor transcripts in major depressive disorder is not epigenetically programmed
Abstract
Hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis is one of the most consistent findings in major depressive disorder (MDD). Impaired HPA feedback may be due to the lower glucocorticoid receptor (GR) or mineralocorticoid receptor (MR) levels in the forebrain. GR levels are transcriptionally controlled by multiple untranslated alternative first exons, each with its own promoter providing a mechanism for tissue-specific fine-tuning of GR levels. Recently epigenetic methylation of these GR promoters was shown to modulate hippocampal GR levels. Here we investigate in post-mortem brain tissues whether in MDD HPA axis hyperactivity may be due to epigenetic modulation of GR transcript variants. Levels of GRalpha, GRbeta and GR-P transcripts were homogeneous throughout the limbic system, with GRalpha being the most abundant (83%), followed by GR-P (5-6%) while GRbeta was barely detectable (0.02%). Among the alternative first exons, 1B and 1C were the most active, while 1E and 1J showed the lowest expression and transcript 1F expressed intermediate levels of about 1%. In MDD, total GR levels were unaltered, although GRalpha was decreased in the amygdala and cingulate gyrus (p<0.05); transcripts containing exons 1B, 1C and 1F were lower, and 1D and1J were increased in some regions. NGFI-A, a transcription factor of exon 1F was down-regulated in the hippocampus of MDD patients; concomitantly exon 1F expression was reduced. Bisulphite sequencing of the alternative promoters showed low methylation levels in both MDD and control brains. Promoter 1F was uniformly unmethylated, suggesting that reduced 1F transcript levels are not linked to promoter methylation but to the observed dearth of NGFI-A. Previous studies showed high methylation levels in the 1F promoter, associated with childhood abuse. Provided our donors were not abused, our results suggest that the pathomechanism of MDD is similar but nevertheless distinct from that of abuse victims, explaining the clinical similarity of both conditions and that susceptibility to depression may be either predisposed by early trauma or developed independent of such a condition. However, this should be further confirmed in dedicated studies in larger cohorts.
Copyright 2009 Elsevier Ltd. All rights reserved.
Similar articles
-
Glucocorticoid receptor gene expression and promoter CpG modifications throughout the human brain.J Psychiatr Res. 2013 Nov;47(11):1597-607. doi: 10.1016/j.jpsychires.2013.07.022. Epub 2013 Aug 12. J Psychiatr Res. 2013. PMID: 23948638
-
Decreased expression of mineralocorticoid receptor mRNA and its splice variants in postmortem brain regions of patients with major depressive disorder.J Psychiatr Res. 2011 Jul;45(7):871-8. doi: 10.1016/j.jpsychires.2010.12.002. Epub 2010 Dec 30. J Psychiatr Res. 2011. PMID: 21195417
-
Associations between promoter usage and alternative splicing of the glucocorticoid receptor gene.J Mol Endocrinol. 2007 Feb;38(1-2):91-8. doi: 10.1677/jme.1.02117. J Mol Endocrinol. 2007. PMID: 17242172
-
Transcriptional control of the glucocorticoid receptor: CpG islands, epigenetics and more.Biochem Pharmacol. 2010 Dec 15;80(12):1860-8. doi: 10.1016/j.bcp.2010.06.037. Epub 2010 Jul 1. Biochem Pharmacol. 2010. PMID: 20599772 Review.
-
Tissue specific glucocorticoid receptor expression, a role for alternative first exon usage?Biochem Pharmacol. 2006 Nov 30;72(11):1529-37. doi: 10.1016/j.bcp.2006.07.005. Epub 2006 Aug 22. Biochem Pharmacol. 2006. PMID: 16930562 Review.
Cited by
-
The Yin and Yang of the oxytocin and stress systems: opposites, yet interdependent and intertwined determinants of lifelong health trajectories.Front Endocrinol (Lausanne). 2024 Apr 16;15:1272270. doi: 10.3389/fendo.2024.1272270. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38689729 Free PMC article.
-
Major depressive disorder: hypothesis, mechanism, prevention and treatment.Signal Transduct Target Ther. 2024 Feb 9;9(1):30. doi: 10.1038/s41392-024-01738-y. Signal Transduct Target Ther. 2024. PMID: 38331979 Free PMC article. Review.
-
Influence of Mild Chronic Stress and Social Isolation on Acute Ozone-Induced Alterations in Stress Biomarkers and Brain-Region-Specific Gene Expression in Male Wistar-Kyoto Rats.Antioxidants (Basel). 2023 Nov 3;12(11):1964. doi: 10.3390/antiox12111964. Antioxidants (Basel). 2023. PMID: 38001817 Free PMC article.
-
Epigenetic regulation in major depression and other stress-related disorders: molecular mechanisms, clinical relevance and therapeutic potential.Signal Transduct Target Ther. 2023 Aug 30;8(1):309. doi: 10.1038/s41392-023-01519-z. Signal Transduct Target Ther. 2023. PMID: 37644009 Free PMC article. Review.
-
The role of microRNAs in depression.Front Pharmacol. 2023 Mar 29;14:1129186. doi: 10.3389/fphar.2023.1129186. eCollection 2023. Front Pharmacol. 2023. PMID: 37063278 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical